<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma"</p><p></p><p>International Journal of Clinical Practice 2007;61(11):1874-1883.</p><p>Published online Jan 2007</p><p>PMCID:PMC2228375.</p><p>© 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd</p> DPI, dry-powder inhaler; pMDI, pressurised metered-dose inhale
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
The use of a combination of the inhaled glucocorticosteroid budesonide and beta2-selective long-acti...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
BACKGROUND: Previous single-dose crossover studies have established therapeutic equivalence of formo...
IMPORTANCE OF THE FIELD: Asthma is a heterogeneous disease with various components that may contribu...
Aim: To demonstrate the non-inferiority of extrafine beclomethasone/formoterol Fumarate (BDP/FF) dry...
<p><b>Copyright information:</b></p><p>Taken from "Effect of budesonide/formoterol maintenance and r...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol/fluticasone stable-dose treatment comp...
Aims: To demonstrate the noninferiority of extrafine beclomethasone/formoterol fumarate (BDP/FF) dry...
The present study was designed to compare the fixed combination of beclomethasone and formoterol in ...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
In 3 open-label studies, the systemic bioavailability of budesonide and formoterol administered via ...
SummaryRationaleTo assess equivalence of twice daily (bid) budesonide/formoterol (BUD/FM) 160/4.5 μg...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
The use of a combination of the inhaled glucocorticosteroid budesonide and beta2-selective long-acti...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
BACKGROUND: Previous single-dose crossover studies have established therapeutic equivalence of formo...
IMPORTANCE OF THE FIELD: Asthma is a heterogeneous disease with various components that may contribu...
Aim: To demonstrate the non-inferiority of extrafine beclomethasone/formoterol Fumarate (BDP/FF) dry...
<p><b>Copyright information:</b></p><p>Taken from "Effect of budesonide/formoterol maintenance and r...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol/fluticasone stable-dose treatment comp...
Aims: To demonstrate the noninferiority of extrafine beclomethasone/formoterol fumarate (BDP/FF) dry...
The present study was designed to compare the fixed combination of beclomethasone and formoterol in ...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
In 3 open-label studies, the systemic bioavailability of budesonide and formoterol administered via ...
SummaryRationaleTo assess equivalence of twice daily (bid) budesonide/formoterol (BUD/FM) 160/4.5 μg...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
The use of a combination of the inhaled glucocorticosteroid budesonide and beta2-selective long-acti...